Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220406054433N1Phase 3Completed
Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Iran University of Medical Sciences. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220406054433N1.